Company: PCRX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001396814-25-000041
Chunk: 9

Company: Pacira BioSciences, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 9
---
Item 16.    Form 10-K Summary

None.

Pacira BioSciences, Inc.  |  2024 Annual Report on Form 10-K  |  Page 92

Table of Contents

SIGNATURESPursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

PACIRA BIOSCIENCES, INC./s/ FRANK D. LEEDate:February 27, 2025By: Frank D. LeeChief Executive Officer and Director

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated and on February 27, 2025.

Principal Executive OfficerDirectors/s/ FRANK D. LEE/s/ MARCELO BIGAL/s/ ABRAHAM CEESAYFrank D. LeeMarcelo BigalAbraham CeesayChief Executive Officer and Director/s/ CHRISTOPHER J. CHRISTIE/s/ MARK FROIMSONPrincipal Financial OfficerChristopher J. ChristieMark Froimson/s/ SHAWN M. CROSS/s/ MARK KRONENFELD/s/ MICHAEL YANGShawn M. CrossMark KronenfeldMichael YangChief Financial Officer/s/ ALETHIA YOUNG/s/ LAURA BREGEPrincipal Accounting OfficerAlethia YoungLaura BregeChair of the Board of Directors/s/ LAUREN RIKERLauren RikerSenior Vice President, Finance

Pacira BioSciences, Inc.  |  2024 Annual Report on Form 10-K  |  Page 93

Table of Contents

PACIRA BIOSCIENCES, INC.

ANNUAL REPORT ON FORM 10-K

FOR THE YEAR ENDED DECEMBER 31, 2024

INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTSPage #Report of Independent Registered Public Accounting FirmF-2Auditor Name:KPMG LLPAuditor Location:Short Hills, NJAuditor Firm ID:185Consolidated Balance Sheets as of December 31, 2024 and 2023F-4Consolidated Statements of Operations for the years ended December 31, 2024, 2023 and 2022F-5Cons